Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-05-06 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CARQUEIRANNE (83320), Var
PHARMACIE DU CARTHAGE : revenue, balance sheet and financial ratios
PHARMACIE DU CARTHAGE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CARQUEIRANNE (83320),
this company of category PME
shows in 2024 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CARTHAGE (SIREN 512276627)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 902 344 €
N/C
2 825 086 €
2 702 019 €
2 490 011 €
2 148 456 €
2 033 590 €
2 041 931 €
1 946 972 €
Net income
47 664 €
151 289 €
204 102 €
316 797 €
224 432 €
157 361 €
176 985 €
157 607 €
104 151 €
140 975 €
EBITDA
N/C
225 062 €
N/C
407 485 €
311 294 €
223 237 €
245 572 €
227 413 €
177 698 €
244 231 €
Net margin
N/C
5.2%
N/C
11.2%
8.3%
6.3%
8.2%
7.8%
5.1%
7.2%
Revenue and income statement
In 2025, PHARMACIE DU CARTHAGE generates positive net income of 48 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 141 k€ -> 48 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
47 664 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 499%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
499.076%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
15.265%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU CARTHAGE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
145.053
100.294
85.05
70.451
84.555
68.64
54.411
49.447
41.662
499.076
Financial autonomy
36.939
45.069
48.527
52.52
48.836
51.303
56.349
61.118
64.309
15.265
Repayment capacity
7.797
7.969
6.149
4.336
6.002
3.887
2.795
None
4.518
None
Cash flow / Revenue
7.365%
5.371%
7.022%
8.317%
6.546%
8.375%
10.325%
None%
5.125%
None%
Sector positioning
Debt ratio
499.082025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Watch+34 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU CARTHAGE (499.08) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
15.27%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch-41 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU CARTHAGE (15.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
4.52 years2024
2024
Q1: 0.52 years
Med: 3.18 years
Q3: 7.6 years
Average
In 2024, the repayment capacity of PHARMACIE DU CARTHAGE (4.52) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 337.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
337.916
Liquidity indicators evolution PHARMACIE DU CARTHAGE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
222.31
159.865
228.202
202.225
190.809
173.18
213.473
290.11
268.46
337.916
Interest coverage
17.953
12.993
11.181
2.061
2.572
1.705
1.16
None
1.58
None
Sector positioning
Liquidity ratio
337.922025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent
In 2025, the liquidity ratio of PHARMACIE DU CARTHAGE (337.92) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.58x2024
2024
Q1: 0.0x
Med: 2.34x
Q3: 7.73x
Average
In 2024, the interest coverage of PHARMACIE DU CARTHAGE (1.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CARTHAGE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
199 545 €
202 764 €
260 401 €
321 559 €
311 177 €
241 182 €
280 362 €
0 €
352 257 €
0 €
Inventory turnover (days)
37
32
41
46
38
36
38
0
38
0
Customer payment term (days)
4
5
3
6
6
6
7
0
7
0
Supplier payment term (days)
39
31
38
40
37
42
45
0
29
0
Positioning of PHARMACIE DU CARTHAGE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU CARTHAGE is estimated at
757 148 €
(range 513 804€ - 1 188 069€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
513k€757k€1188k€
757 148 €Range: 513 804€ - 1 188 069€
NAF 5 année 2025
Valuation method used
Net Income Multiple
47 664 €
×
15.9x
=757 148 €
Range: 513 804€ - 1 188 070€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CARTHAGE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CARTHAGE
What is the revenue of PHARMACIE DU CARTHAGE ?
The revenue of PHARMACIE DU CARTHAGE in 2024 is 2.9 M€.
Is PHARMACIE DU CARTHAGE profitable?
Yes, PHARMACIE DU CARTHAGE generated a net profit of 48 k€ in 2025.
Where is the headquarters of PHARMACIE DU CARTHAGE ?
The headquarters of PHARMACIE DU CARTHAGE is located in CARQUEIRANNE (83320), in the department Var.
Where to find the tax return of PHARMACIE DU CARTHAGE ?
The tax return of PHARMACIE DU CARTHAGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CARTHAGE operate?
PHARMACIE DU CARTHAGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart